Comment by
Albr035 on Apr 27, 2022 8:17am
Pain management, eye treatment, ... Focus on one product and get approved, jumping around tell you failed!
Comment by
Golddetector on Apr 27, 2022 9:58am
CQDM is arranging that I guess. It is non profit organization. Not sure if tetra is here bcz of their money. Most likely is technical expertise. It will be good if get more details. I was waiting for a nr to provide more details but I guess we have to wait.
Comment by
NSX001 on Apr 27, 2022 10:30am
It seems a little odd that no info has been released to TBP shareholders. Your right though, It appears that CQDM is the front organization on this. Funding seems to be coming from: MEI ($1,268,682.00), a very specific amount. Mitacs ? NSERC ? Altus Formulation ? & Tetra Biopharma ? Need more information before we celebrate this news. NSX001
Comment by
Golddetector on Apr 27, 2022 1:44pm
There are two dates on that news April 26 And April 28 maybe it was planned for tomorrow. We shall see I guess https://cqdm.org/news-and-events/cqdm-funds-an-innovative-project-with-altus-formulation-and-tetra-bio-pharma-to-develop-first-in-class-treatments-for-ocular-inflammation/
Comment by
Savage97 on Apr 27, 2022 11:41am
!!!!!!!!!!!FANTASTIC NEWS!!!!!!!!!!!! Investors will continue backing TBP as long as they keep succeeding with their clinical trials. $$$